GlassScriptPhysician profile
Seth W Meskin
NPI 1346273273
$647.60
in general payments reported to CMS, 2019-2025
16 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2021: $85.79 · 2022: $67.87 · 2023: $43.34 · 2024: $85.77 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $248.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $82.44 | 2019-2024 | Cequa |
| Kala Pharmaceuticals, INC. | $68.49 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $66.58 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $65.87 | 2024-2025 | Xdemvy |
| Allergan, INC. | $54.76 | 2019-2022 | |
| Dompe US, INC. | $52.29 | 2019-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $44.93 | 2021-2022 | |
| Alcon Vision LLC | $40.08 | 2022-2025 | Tryptyr |
| Bausch & Lomb Americas INC. | $34.54 | 2022-2024 | Envista Mx60 Iol |
| Abbvie INC. | $28.10 | 2025 | |
| Horizon Therapeutics Plc | $20.69 | 2023 | Tepezza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.02 | 2021 | |
| Aerie Pharmaceuticals, INC. | $19.05 | 2019 | |
| Eyevance Pharmaceuticals LLC | $17.53 | 2019 | |
| Harrow Eye, LLC | $17.37 | 2024 | Vevye |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $14.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Meskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.